For further information about Anesiva leadership in the development of products for pain management, and an overview of the clinical challenges addressed by their drug candidates, Forward-looking statements Statements.. About Anesiva and its Diverse Pipeline of Pain ProductsAnesiva, is a late-stage biopharmaceutical company a leader in the a leader in the development and commercialization of novel therapeutic treatments for pain. In addition to 1207, the company has two drug candidates in development for multiple pain – related indications, the most advanced of which Zingo , has completed Phase 3 clinical trials. The second product in the pipeline , has been shown to reduce pain after only a single administration for weeks months in multiple settings in numerous mid-stage clinical trials for site-specific, moderate-to – severe pain.
ASTRO is the largest radiation oncology society in the world, with more than 8,000 members in in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is to promote the practice of radiation oncology by promoting excellence in patient care, providing opportunities for educational and professional development, promoting research and disseminating research results and representing radiation oncology devoted in a rapidly evolving socioeconomic healthcare. Communications Director,tant Communications Director, American Society for Therapeutic Radiology and Oncology 12500 Fair Lakes Circle, Suite 375 Fairfax, VA 22033 800-962-7876 703-227-0141. Continue reading